Relay Therapeutics annual operating margin
2020
2021
2022
2023
2024
2025
Relay Therapeutics's operating margin was −1,971.59% for fiscal 2025.
View full Relay Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,971.59% | +1750.48 pp |
| 2024 | 2024-12-31 | −3,722.07% | −2261.96 pp |
| 2023 | 2023-12-31 | −1,460.11% | +20210.78 pp |
| 2022 | 2022-12-31 | −21,670.89% | −9630.68 pp |
| 2021 | 2021-12-31 | −12,040.21% | −11972.71 pp |
| 2020 | 2020-12-31 | −67.51% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −25,949.71% | −24844.51 pp |
| Q1 2026 | 2026-03-31 | −2,619.67% | −1716.67 pp |
| Q4 2025 | 2025-12-31 | −866.28% | −574.33 pp |
| Q2 2025 | 2025-06-30 | −11,351.11% | +77766.54 pp |
| Q1 2025 | 2025-03-31 | −1,105.21% | +43663.38 pp |
| Q1 2024 | 2024-03-31 | −903.00% | +27891.86 pp |
| Q3 2023 | 2023-09-30 | −291.95% | +24676.66 pp |
| Q2 2023 | 2023-06-30 | −89,117.65% | −67799.56 pp |
| Q1 2023 | 2023-03-31 | −44,768.58% | −29799.37 pp |
| Q4 2022 | 2022-12-31 | −28,794.86% | −16850.77 pp |
| Q3 2022 | 2022-09-30 | −24,968.60% | −15810.95 pp |
| Q2 2022 | 2022-06-30 | −21,318.08% | +1617.94 pp |
| Q1 2022 | 2022-03-31 | −14,969.21% | −10514.91 pp |
| Q4 2021 | 2021-12-31 | −11,944.09% | — |
| Q3 2021 | 2021-09-30 | −9,157.66% | — |
| Q2 2021 | 2021-06-30 | −22,936.02% | — |
| Q1 2021 | 2021-03-31 | −4,454.31% | — |
Over the last five reported fiscal years, Relay Therapeutics's operating margin decreased from −67.51% to −1,971.59%, a change of −1904.09 percentage points. The latest reported quarter, Q2 2026, shows −25,949.71%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Relay Therapeutics filings at SEC.gov ↗